Roche: controlled risks?




By




rock rose 1.3% to 294 CHF on Tuesday, despite JP Morgan which went from ‘neutral’ to ‘underweight’ on the Swiss laboratory by targeting a price of 275 CHF. As part of a sector note, the broker fears that investors…

This stock market news is for subscribers only Privileges


Test our stock market advice for €1, without obligation


I subscribe

Already subscribed? Login

Discover Boursier.com services Privileges


  • 8:30 am
    Recognition of the day

  • 4 to 5 stock tips per day


    4 to 5 tips
    scholarship holders per day

  • weekly newsletter


    Weekly Newsletter “Opportunities”



  • Wallets
    defensive, balanced
    and dynamic


Learn more


©2023 Boursier.com



Source link -87